These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25395703)

  • 1. The plights of African resources patenting through the lenses of the World Trade Organisation: an assessment of South Africa's rooibos tea's labyrith journey.
    Amusan L
    Afr J Tradit Complement Altern Med; 2014; 11(5):41-7. PubMed ID: 25395703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POLITICS OF BIOPIRACY: AN ADVENTURE INTO HOODIA/XHOBA PATENTING IN SOUTHERN AFRICA.
    Amusan L
    Afr J Tradit Complement Altern Med; 2017; 14(1):103-109. PubMed ID: 28480387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement.
    Motari M; Nikiema JB; Kasilo OMJ; Kniazkov S; Loua A; Sougou A; Tumusiime P
    BMC Public Health; 2021 Mar; 21(1):490. PubMed ID: 33706726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global lessons from South Africa's rooibos compensation agreement.
    Nature; 2019 Nov; 575(7782):258. PubMed ID: 31719705
    [No Abstract]   [Full Text] [Related]  

  • 5. A review of the bioactivity of South African herbal teas: rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia).
    McKay DL; Blumberg JB
    Phytother Res; 2007 Jan; 21(1):1-16. PubMed ID: 16927447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopiracy of natural products and good bioprospecting practice.
    Efferth T; Banerjee M; Paul NW; Abdelfatah S; Arend J; Elhassan G; Hamdoun S; Hamm R; Hong C; Kadioglu O; Naß J; Ochwangi D; Ooko E; Ozenver N; Saeed ME; Schneider M; Seo EJ; Wu CF; Yan G; Zeino M; Zhao Q; Abu-Darwish MS; Andersch K; Alexie G; Bessarab D; Bhakta-Guha D; Bolzani V; Dapat E; Donenko FV; Efferth M; Greten HJ; Gunatilaka L; Hussein AA; Karadeniz A; Khalid HE; Kuete V; Lee IS; Liu L; Midiwo J; Mora R; Nakagawa H; Ngassapa O; Noysang C; Omosa LK; Roland FH; Shahat AA; Saab A; Saeed EM; Shan L; Titinchi SJ
    Phytomedicine; 2016 Feb; 23(2):166-73. PubMed ID: 26926178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

  • 8. Rooibos settlement omits other marginalized people.
    Ives S; Wynberg R; Dutfield G
    Nature; 2020 Jan; 577(7790):318. PubMed ID: 31937966
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrating biodiversity management and indigenous biopiracy protection to promote environmental justice and global health.
    Mackey TK; Liang BA
    Am J Public Health; 2012 Jun; 102(6):1091-5. PubMed ID: 22515858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodiversity, biopiracy and benefits: what allegations of biopiracy tell us about intellectual property.
    Hamilton C
    Dev World Bioeth; 2006 Dec; 6(3):158-73. PubMed ID: 17038007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to affordable HIV/AIDS drugs: the human rights obligations of multinational pharmaceutical corporations.
    Ferreira L
    Fordham Law Rev; 2002 Dec; 71(3):1133-79. PubMed ID: 12523370
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of processing on the microbial risk associated with Rooibos (Aspalathus linearis) tea.
    Gouws P; Hartel T; van Wyk R
    J Sci Food Agric; 2014 Dec; 94(15):3069-78. PubMed ID: 24789759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. South African herbal teas: Aspalathus linearis, Cyclopia spp. and Athrixia phylicoides--a review.
    Joubert E; Gelderblom WC; Louw A; de Beer D
    J Ethnopharmacol; 2008 Oct; 119(3):376-412. PubMed ID: 18621121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 25 years after the `Rio Convention'--Lessons learned in the context of sustainable development and protecting indigenous and local knowledge.
    Heinrich M; Hesketh A
    Phytomedicine; 2019 Feb; 53():332-343. PubMed ID: 30318154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights].
    Allard Soto R
    Salud Colect; 2015 Mar; 11(1):9-21. PubMed ID: 25853827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intellectual property rights and right of access to medicines].
    Velásquez G
    Med Trop (Mars); 2006 Dec; 66(6):526-8. PubMed ID: 17286013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic optimisation of the reversed phase liquid chromatographic separation of rooibos tea (Aspalathus linearis) phenolics on conventional high performance liquid chromatographic instrumentation.
    Beelders T; Sigge GO; Joubert E; de Beer D; de Villiers A
    J Chromatogr A; 2012 Jan; 1219():128-39. PubMed ID: 22153205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Phenolic Compounds in Rooibos Tea (Aspalathus linearis) with a Comparison of Flavonoid-Based Compounds in Natural Populations of Plants from Different Regions.
    Stander MA; Van Wyk BE; Taylor MJC; Long HS
    J Agric Food Chem; 2017 Nov; 65(47):10270-10281. PubMed ID: 29063755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the health and economic implications of patent protection, with a specific focus on Thailand.
    Yamabhai I; Smith RD
    Health Res Policy Syst; 2012 Aug; 10():24. PubMed ID: 22849392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rooibos (Aspalathus linearis) offers cardiac protection against ischaemia/reperfusion in the isolated perfused rat heart.
    Pantsi WG; Marnewick JL; Esterhuyse AJ; Rautenbach F; van Rooyen J
    Phytomedicine; 2011 Nov; 18(14):1220-8. PubMed ID: 21982437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.